Selection from HEOR Bibliography
| Search criteria | ||||
| Slovakia |
||||
| The longitudinal relationship between fatigue, depression, anxiety, disability, and adherence with cognitive status in patients with early multiple sclerosis treated with interferon beta-1a | ||||
| Hanne van Ballegooijen, Karin van der Hiele, Christian Enzinger, Gert de Voer, Leo H. Visser, on behalf of the CONFIDENCE Study Group | ||||
| IQVIA Netherlands, Real World Evidence, Netherlands b Department of Psychology, Health, Medical and Neuropsychology Unit, Leiden University, Leiden, Netherlands c Medical University of Graz, Graz, Austria d Merck BV, Schiphol-Rijk, The Netherlands, an affiliate of Merck KGaA, Germany e St Elisabeth Tweesteden Hospital, Tilburg, the Netherlands | ||||
| eNeurologicalSci, Volume 28, 2022, 100409, ISSN 2405-6502, https://doi.org/10.1016/j.ensci.2022.100409. (https://www.sciencedirect.com/science/article/pii/S2405650222000181) |
||||
| , Article | ||||
| , Austria, Belgium, Netherlands , Slovakia | ||||
| Abstract: https://www.sciencedirect.com/science/article/pii/S2405650222000181 | ||||
| Condition | Year | Language | Analysis type | |
| , Drug safety, Drug Utlization Study, Neurological disorders | 2022 | English | , Clinical setting: hospital, clinical setting: Secondary care, Epidemiological study, Population Based Study, Prospective study | |
| A Survey Among Health Care Professionals to Assess Their Knowledge and Understanding on Darzalex® (Daratumumab) Educational Materials Regarding the Risk of Interference for Blood Typing in 12 European Countries | ||||
| Mathieu Rosé, Intissar Bourahla, Alessandro Ghiddi, Assem Al-Akabawi, Edmond Chan, Massoud Toussi | ||||
| IQVIA, Courbevoie, France; Janssen EMEA, Medical Affairs, Italy; Janssen EMEA, Medical Affairs, UK | ||||
| Presented at ISPE’s 35th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE 2019), August 24–28, 2019 at the Pennsylvania Convention Center, Philadelphia, PA, USA. |
||||
| , Poster | ||||
| , Austria, Czech, Denmark, Finland, France, Germany, Hungary, Norway, Slovakia, Spain, Sweden, Switzerland | ||||
| Abstract: https://www.coodoc.com/pages/p1822-Daratumumab-ICPE-2019 | ||||
| Condition | Year | Language | Analysis type | |
| , Hematology, Oncology | 2019 | English | , Public Health, Survey research | |
| Patient and caregiver indirect costs after acute cardiovascular events in Europe. | ||||
| Sidelnikov E1, Gerlier L2, Kutikova L1, Amarenco P3, Kotseva K4, Annemans L5 | ||||
| 1 Amgen (Europe) GmbH, Zug, Switzerland 2 IQVIA, Zaventem, Belgium 3 Paris-Diderot-Sorbonne University, Paris, France 4 National Heart & Lung Institute, Imperial College London, London, UK 5 Ghent University, Ghent, Belgium | ||||
| ISPOR 21st Annual European Congress, 2018, November 10-14, Barcelona, Spain |
||||
| , Oral presentation | ||||
| , Austria, Bulgaria, Croatia, Czech, Denmark, Finland, Germany, Greece, Italy, Norway, Romania, Slovakia, Slovenia | ||||
| Abstract: https://tools.ispor.org/ScientificPresentationsDatabase/Presentation/84816?pdfid=58963 | ||||
| Condition | Year | Language | Analysis type | |
| , Cardiovascular disease, Health economics | 2018 | English | , Burden of illness, Cost of illness | |
| Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature. | ||||
| Svedman FC1, Pillas D2, Taylor A2, Kaur M2, Linder R3, Hansson J1. | ||||
| 1Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden. 2Centre for Observational Research, Amgen Ltd, Uxbridge, UK. 3IMS Health Sweden, Stockholm, Sweden. | ||||
| Clinical Epidemiology |
||||
| , Article | ||||
| , Australia, Austria, Belgium, Bulgaria, Croatia, Czech, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Israel, Italy, Netherlands, Norway, Poland, Portugal, Russian Federation, Serbia and Montenegro, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, UK | ||||
| Abstract: http://www-ncbi-nlm-nih-gov.proxy.kib.ki.se/pmc/articles/PMC4887072/ | ||||
| Condition | Year | Language | Analysis type | |
| , Oncology | 2016 | English | , Literature Review | |
| Survey on appropriateness of use of nimesulide in nine European countries | ||||
| Franchi S1, Heiman F2, Visentin E2, Sacerdote P1. | ||||
| 1Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milan, Italy. 2Cegedim Strategic Data Medical Research Srl, Milan, Italy. | ||||
| Drug, Healthcare and Patient Safety 2015:7 51-55 |
||||
| , Article | ||||
| , Bulgaria, Czech, Greece, Hungary, Italy, Poland, Portugal, Romania, Slovakia | ||||
| Condition | Year | Language | Analysis type | |
| , Pain | 2015 | English | , Survey research | |
| Health economic evaluation of canagliflozin in the treatment of type 2 diabetes mellitus in Slovakia | ||||
| Troelsgaard A1, Pitcher A2, Binder R3, Stetka R4, Ondrusova M5, Lovato E2, Hemels M1 | ||||
| Janssen A/S, Birkerød, Denmark, 2IMS Health, London, UK, 3Janssen, Bratislava, Slovak Republic, 4Pharm-In, Ltd, Bratislava, Slovak Republic, 5Pharm-In Ltd, Bratislava, Slovak Republic | ||||
| ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
||||
| , Poster | ||||
| , Slovakia | ||||
| Condition | Year | Language | Analysis type | |
| , Diabetes | 2014 | English | , Economic evaluation | |
| Prevention of stroke in patients with Atrial Fibrillation: Cost-Utility Analysis of Rivaroxaban versus Warfarin in Slovakia | ||||
| Psenkova M1, Lukac M2, Mackovicova S3, Stachova M2, Bielik J4, Pietsch GA5, Asukai Y6, Lloyd A6, Evers T7 | ||||
| 1Pharm-In, Bratislava, Slovak Republic, 2Bayer, Bratislava, Slovak Republic, 3Pharm-In, spol. s r.o., Bratislava, Slovak Republic, 4Trencin University, Trencin, Slovak Republic, 5Bayer Schering Pharma AG, Wupertal, GA, Germany, 6IMS Health, London, UK, 7Bayer Schering Pharma AG, Wuppertal, Germany | ||||
| ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany |
||||
| , Poster | ||||
| , Slovakia | ||||
| Abstract: http://www.ispor.org/congresses/Berlin1112/Posters2.aspx | ||||
| Condition | Year | Language | Analysis type | |
| , Cardiovascular disease | 2012 | English | , Cost utility | |
| Cost-utility analysis of Rivaroxaban compared with Enoxaparin in prevention of venous thromboembolism after total hip replacement in Slovakia | ||||
| Pereira R1, Diamantopoulos A2, Bielik J3, Lees M4, Tomek D5, Lukac M6 | ||||
| 1IMS Health, Barcelona, Spain, 2IMS Health HEOR, London, UK, 3University of A.Dubcek in Trencin, Bratislava, Slovak Republic, 4Bayer plc, Uxbridge, UK, 5Slovak Society for Pharmacoeconomics, Bratislava, Slovak Republic, 6Faculty of Public Health at Slovak Medical University, Bratislava, Slovak Republic | ||||
| ISPOR 15th Annual International Meeting, May 15-19, 2010, Atlanta, GA, USA |
||||
| , Poster | ||||
| , Slovakia | ||||
| Abstract: http://www.ispor.org/meetings/atlanta0510/Posters3.aspx | ||||
| Condition | Year | Language | Analysis type | |
| , Vascular disease | 2010 | English | , | |